Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by IDEAYA Biosciences, Inc. on June 9, 2022. The filing details the voting results for director elections and the ratification of the independent auditor. As of the record date (April 12, 2022), 38,632,622 shares of common stock were outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Proposal 1: Election of Class III Directors
Three nominees were elected to hold office until the 2025 annual meeting. The vote tabulation was as follows:
- Susan L. Kelley, M.D.: 30,165,016 votes For; 3,442,946 votes Withheld; 2,961,916 Broker Non-Votes.
- Scott W. Morrison: 20,373,793 votes For; 13,234,169 votes Withheld; 2,961,916 Broker Non-Votes.
- Jeffrey L. Stein, Ph.D.: 18,072,384 votes For; 15,535,578 votes Withheld; 2,961,916 Broker Non-Votes.
Proposal 2: Ratification of Independent Auditor
Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2022.
- Votes For: 36,533,072
- Votes Against: 36,756
- Abstentions: 50
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of stockholder voting results.
Investor Verification Checklist
- Verify the final composition of the Board of Directors following the election of the three Class III nominees.
- Confirm the engagement of PricewaterhouseCoopers LLP for the 2022 fiscal year audit.
- Review the definitive proxy statement (Schedule 14A) filed on April 26, 2022, for detailed biographies of the elected directors and further context on the proposals.
- Note the significant number of votes withheld for Scott W. Morrison and Jeffrey L. Stein, Ph.D., which may indicate shareholder sentiment regarding board composition.